Access Pharmaceuticals, Chemex Pharmaceuticals Inc. deal

The companies signed a definitive merger agreement under which CHMX (Fort Lee, N.J.) will exchange 13.8 million of its common shares for all outstanding shares of Access (Dallas). The surviving entity, to be named Access Pharmaceuticals Inc., will have 22.8 million shares outstanding and will be based in Dallas. ...